BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 35277970)

  • 1. Global patterns in testicular cancer incidence and mortality in 2020.
    Znaor A; Skakkebaek NE; Rajpert-De Meyts E; Kuliš T; Laversanne M; Gurney J; Sarfati D; McGlynn KA; Bray F
    Int J Cancer; 2022 Sep; 151(5):692-698. PubMed ID: 35277970
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Global trends in testicular cancer incidence and mortality.
    Rosen A; Jayram G; Drazer M; Eggener SE
    Eur Urol; 2011 Aug; 60(2):374-9. PubMed ID: 21612857
    [TBL] [Abstract][Full Text] [Related]  

  • 3. International variations and trends in testicular cancer incidence and mortality.
    Znaor A; Lortet-Tieulent J; Jemal A; Bray F
    Eur Urol; 2014 Jun; 65(6):1095-106. PubMed ID: 24268506
    [TBL] [Abstract][Full Text] [Related]  

  • 4. International patterns and trends in testicular cancer incidence, overall and by histologic subtype, 1973-2007.
    Trabert B; Chen J; Devesa SS; Bray F; McGlynn KA
    Andrology; 2015 Jan; 3(1):4-12. PubMed ID: 25331326
    [TBL] [Abstract][Full Text] [Related]  

  • 5. International variations in bladder cancer incidence and mortality.
    Chavan S; Bray F; Lortet-Tieulent J; Goodman M; Jemal A
    Eur Urol; 2014 Jul; 66(1):59-73. PubMed ID: 24451595
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recent global trends in testicular cancer incidence and mortality.
    Park JS; Kim J; Elghiaty A; Ham WS
    Medicine (Baltimore); 2018 Sep; 97(37):e12390. PubMed ID: 30213007
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Worldwide Distribution, Risk Factors, and Temporal Trends of Testicular Cancer Incidence and Mortality: A Global Analysis.
    Huang J; Chan SC; Tin MS; Liu X; Lok VT; Ngai CH; Zhang L; Lucero-Prisno DE; Xu W; Zheng ZJ; Chiu PK; Ng AC; Enikeev D; Nicol D; Spiess PE; Laguna P; Teoh JY; Wong MCS
    Eur Urol Oncol; 2022 Oct; 5(5):566-576. PubMed ID: 35863988
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Global patterns of non-Hodgkin lymphoma in 2020.
    Mafra A; Laversanne M; Gospodarowicz M; Klinger P; De Paula Silva N; Piñeros M; Steliarova-Foucher E; Bray F; Znaor A
    Int J Cancer; 2022 Nov; 151(9):1474-1481. PubMed ID: 35695282
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Burden of testicular, paratesticular and extragonadal germ cell tumours in Europe.
    Trama A; Mallone S; Nicolai N; Necchi A; Schaapveld M; Gietema J; Znaor A; Ardanaz E; Berrino F;
    Eur J Cancer; 2012 Jan; 48(2):159-69. PubMed ID: 22142457
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The epidemiological landscape of multiple myeloma: a global cancer registry estimate of disease burden, risk factors, and temporal trends.
    Huang J; Chan SC; Lok V; Zhang L; Lucero-Prisno DE; Xu W; Zheng ZJ; Elcarte E; Withers M; Wong MCS;
    Lancet Haematol; 2022 Sep; 9(9):e670-e677. PubMed ID: 35843248
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Trends in testicular cancer incidence and mortality in 22 European countries: continuing increases in incidence and declines in mortality.
    Bray F; Richiardi L; Ekbom A; Pukkala E; Cuninkova M; Møller H
    Int J Cancer; 2006 Jun; 118(12):3099-111. PubMed ID: 16395710
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bladder Cancer Incidence and Mortality: A Global Overview and Recent Trends.
    Antoni S; Ferlay J; Soerjomataram I; Znaor A; Jemal A; Bray F
    Eur Urol; 2017 Jan; 71(1):96-108. PubMed ID: 27370177
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Testicular cancer incidence predictions in Europe 2010-2035: A rising burden despite population ageing.
    Znaor A; Skakkebaek NE; Rajpert-De Meyts E; Laversanne M; Kuliš T; Gurney J; Sarfati D; McGlynn KA; Bray F
    Int J Cancer; 2020 Aug; 147(3):820-828. PubMed ID: 31773729
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Testicular cancer incidence to rise by 25% by 2025 in Europe? Model-based predictions in 40 countries using population-based registry data.
    Le Cornet C; Lortet-Tieulent J; Forman D; Béranger R; Flechon A; Fervers B; Schüz J; Bray F
    Eur J Cancer; 2014 Mar; 50(4):831-9. PubMed ID: 24369860
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Global patterns of cardia and non-cardia gastric cancer incidence in 2012.
    Colquhoun A; Arnold M; Ferlay J; Goodman KJ; Forman D; Soerjomataram I
    Gut; 2015 Dec; 64(12):1881-8. PubMed ID: 25748648
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The global landscape of bladder cancer incidence and mortality in 2020 and projections to 2040.
    Zhang Y; Rumgay H; Li M; Yu H; Pan H; Ni J
    J Glob Health; 2023 Sep; 13():04109. PubMed ID: 37712386
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mortality Trends from Urologic Cancers in Europe over the Period 1980-2017 and a Projection to 2025.
    Bertuccio P; Santucci C; Carioli G; Malvezzi M; La Vecchia C; Negri E
    Eur Urol Oncol; 2021 Oct; 4(5):677-696. PubMed ID: 34103280
    [TBL] [Abstract][Full Text] [Related]  

  • 18. International Trends in the Incidence of Testicular Cancer: Lessons from 35 Years and 41 Countries.
    Gurney JK; Florio AA; Znaor A; Ferlay J; Laversanne M; Sarfati D; Bray F; McGlynn KA
    Eur Urol; 2019 Nov; 76(5):615-623. PubMed ID: 31324498
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Estimates of the worldwide mortality from 25 cancers in 1990.
    Pisani P; Parkin DM; Bray F; Ferlay J
    Int J Cancer; 1999 Sep; 83(1):18-29. PubMed ID: 10449602
    [TBL] [Abstract][Full Text] [Related]  

  • 20. International trends in the incidence of testicular cancer, 1973-2002.
    Chia VM; Quraishi SM; Devesa SS; Purdue MP; Cook MB; McGlynn KA
    Cancer Epidemiol Biomarkers Prev; 2010 May; 19(5):1151-9. PubMed ID: 20447912
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.